헬리코박터 파이로리 감염과 대사성질환

키워드

참고문헌 (100)

1. Wotherspoon AC, "Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma", Lancet, 338, pp.1175~1176 (1991)
2. Parsonnet J, "Helicobacter pylori and gastric cancer", Gastroenterol Clin North Am, 22, pp.89~104 (1993)
3. Graham DY, "Effect of H. pylori infection and CagA status on leukocyte counts and liver function tests: extra-gastric manifestations of H. pylori infection", Helicobacter, 3, pp.174~178 (1998)
4. Patel P, "Helicobacter pylori infection in childhood : risk factors and effect on growth", BMJ, 309, pp.1119~1123 (1994)
5. Date Y, "Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans", Endocrinology, 141, pp.4255~4261 (2000)
6. Cummings DE, "A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans", Diabetes, 50, pp.1714~1719 (2001)
7. Tschöp M, "Circulating ghrelin levels are decreased in human obesity", Diabetes, 50, pp.707~709 (2001)
8. Nakazato M, "A role for ghrelin in the central regulation of feeding", Nature, 409, pp.194~198 (2001)
9. Andrews ZB, "UCP2 mediates ghrelin's action on NPY", AgRP neurons by lowering free radicals, 2008, pp.454, 846~851
10. Zhao TJ, "Ghrelin O-acyltransferase(GOAT)is essential for growth hormone-mediated survival of calorie-restricted mice", Proc Natl Acad Sci USA, 107, pp.7467~7472 (2010)
11. Liew PL, "Gastric ghrelin expression associated with Helicobacter pylori infection and chronic gastritis in obese patients", Obes Surg, 16, pp.612~619 (2006)
12. Tatsuguchi A, "Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa", Am J Gastroenterol, 99, pp.2121~2127 (2004)
13. Méndez-Sánchez N, "Effect of Helicobacter pylori infection on gastric ghrelin expression and body weight", Rev Gastroenterol Mex, 72, pp.359~364 (2007)
14. Isomoto H, "Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans", Am J Gastroenterol, 100, pp.1711~1720 (2005)
15. Nweneka CV, "Helicobacter pylori infection and circulating ghrelin levels-a systematic review", BMC Gastroenterol, 11, pp.7~ (2011)
16. Kawashima J, "Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis", J Gastroenterol, 44, pp.1046~1054 (2009)
17. Campana D, "Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis", Clin Endocrinol (Oxf), 67, pp.761~766 (2007)
18. Nwokolo CU, "Plasma ghrelin following cure of Helicobacter pylori", Gut, 52, pp.637~640 (2003)
19. Gokcel A, "Helicobacter pylori has no effect on plasma ghrelin levels", Eur J Endocrinol, 148, pp.423~426 (2003)
20. Abiko Y, "interleukinreceptor type 1-homozygous knockout(IL-1R1-", -)mice, 2005, pp.11, 4148~4153
21. Yon Ho Choe, "Ghrelin Levels in Gastric Mucosa before and after Eradication of Helicobacter pylori", Gut and Liver, 1(2), pp.132~137 (2007), 거트앤리버 발행위원회
22. 최정영, "Ghrelin; Helicobacter pylori 감염 위 질환에 미치는 영향", 대한소화기학회지, 48(2), pp.75~81 (2006), 대한소화기학회
23. 이언숙, "Eradication of Helicobacter pylori Increases Ghrelin mRNA Expression in the Gastric Mucosa", Journal of Korean Medical Science, 25(2), pp.265~271 (2010), 대한의학회
24. Osawa H, "Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori", J Clin Endocrinol Metab, 90, pp.10~16 (2005)
25. Ioannou GN, "Helicobacter pylori seropositivity related to body mass index in the United States?", Aliment Pharmacol Ther, 21, pp.765~772 (2005)
26. Cho I, "Helicobacter pylori and overweight status in the United States : data from the Third National Health and Nutrition Examination Survey", Am J Epidemiol, 162, pp.579~584 (2005)
27. Wu MS, "A casecontrol study of association of Helicobacter pylori infection with morbid obesity in Taiwan", Arch Intern Med, 165, pp.1552~1555 (2005)
28. Perdichizzi G, "Gastric infection by Helicobacter pylori and antral gastritis in hyperglycemic obese and in diabetic subjects", New Microbiol, 19, pp.149~154 (1996)
29. Danesh J, "Risk factors for coronary heart disease and infection with Helicobacter pylori : meta-analysis of 18 studies", BMJ, 316, pp.1130~1132 (1998)
30. Lane JA, "Randomised clinical trial : Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study", Aliment Pharmacol Ther, 33, pp.922~929 (2011)
31. Furuta T, "Effect of Helicobacter pylori infection and its eradication on nutrition", Aliment Pharmacol Ther, 16, pp.799~806 (2002)
32. Fujiwara Y, "Long-term effect of Helicobacter pylori eradication on quality of life, body mass index, and newly developed diseases in Japanese patients with peptic ulcer disease", Hepatogastroenterology, 49, pp.1298~1302 (2002)
33. Eckel RH, "The metabolic syndrome", Lancet, 375, pp.181~183 (2010)
34. Razzouk L, "Ethnic, gender, and age-related differences in patients with the metabolic syndrome", Curr Hypertens Rep, 11, pp.127~132 (2009)
35. Bruce KD, "The developmental origins, mechanisms, and implications of metabolic syndrome", J Nutr, 140, pp.648~652 (2010)
36. Tereshina EV, "Metabolic abnormalities as a basis for agedependent diseases and aging? state of the art", Adv Gerontol, 22, pp.129~138 (2009)
37. Bonora E, "Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity : studies in subjects with various degrees of glucose tolerance and insulin sensitivity", Diabetes Care, 23, pp.57~63 (2000)
38. Wallace TM, "Use and abuse of HOMA modeling", Diabetes Care, 27, pp.1487~1495 (2004)
39. Aslan M, "Insulin resistance in H pylori infection and its association with oxidative stress", World J Gastroenterol, 12, pp.6865~6868 (2006)
40. Eshraghian A, "Helicobacter pylori infection as a risk factor for insulin resistance", Dig Dis Sci, 54, pp.1966~1970 (2009)
41. Gao XY, "Circulating ghrelin", obestatin ratio in subjects with Helicobacter pylori infection, 2009, pp.25, 506~511
42. Gunji T, "Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population", Helicobacter, 14, pp.144~150 (2009)
43. Ozdem S, "Insulin resistance in children with Helicobacter pylori infection", J Endocrinol Invest, 30, pp.236~240 (2007)
44. Park SH, "Helicobacter pylori eradication has no effect on metabolic and inflammatory parameters", J Natl Med Assoc, 97, pp.508~513 (2005)
45. So WY, "Low plasma adiponectin level, white blood cell count and Helicobacter pylori titre independently predict abnormal pancreatic beta-cell function", Diabetes Res Clin Pract, 86, pp.89~95 (2009)
46. Gen R, "Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation", South Med J, 103, pp.190~196 (2010)
47. Polyzos SA, "The association between Helicobacter pylori infection and insulin resistance : a systematic review", Helicobacter, 16, pp.79~88 (2011)
48. Oldenburg B, "High seroprevalence of Helicobacter pylori in diabetes mellitus patients", Dig Dis Sci, 41, pp.458~461 (1996)
49. Gasbarrini A, "Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus", Eur J Gastroenterol Hepatol, 10, pp.469~472 (1998)
50. Salardi S, "Helicobacter pylori and type 1 diabetes mellitus in children", J Pediatr Gastroenterol Nutr, 28, pp.307~309 (1999)
51. Arslan D, "Helicobacter pylori infection in children with insulin dependent diabetes mellitus", J Pediatr Endocrinol Metab, 13, pp.553~556 (2000)
52. Senturk O, "Prevalence and comparisons of five different diagnostic methods for Helicobacter pylori in diabetic patients", Endocr Res, 27, pp.179~189 (2001)
53. Quatrini M, "Helicobacter pylori prevalence in patients with diabetes and its relationship to dyspeptic symptoms", J Clin Gastroenterol, 32, pp.215~217 (2001)
54. Gulcelik NE, "Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy", J Endocrinol Invest, 28, pp.214~217 (2005)
55. Gentile S, "The role of autonomic neuropathy as a risk factor of Helicobacter pylori infection in dyspeptic patients with type 2 diabetes mellitus", Diabetes Res Clin Pract, 42, pp.41~48 (1998)
56. Persico M, "Non-ulcer dyspepsia and Helicobacter pylori in type 2 diabetic patients : association with autonomic neuropathy", Diabetes Res Clin Pract, 31, pp.87~92 (1996)
57. Quadri R, "Helicobacter pylori infection in type 2 diabetic patients", Nutr Metab Cardiovasc Dis, 10, pp.263~266 (2000)
58. Brenner H, "Chronic infection with Helicobacter pylori does not provoke major systemic inflammation in healthy adults : results from a large population-based study", Atherosclerosis, 147, pp.399~403 (1999)
59. Anastasios R, "Helicobacter pylori infection in diabetic patients : prevalence and endoscopic findings", Eur J Intern Med, 13, pp.376~ (2002)
60. Kozák R, "Helicobacter pylori infection in diabetic patients", Orv Hetil, 140, pp.993~995 (1999)
61. Ko GT, "Helicobacter pylori infection in Chinese subjects with type 2 diabetes", Endocr Res, 27, pp.171~177 (2001)
62. Ojetti V, "Role of Helicobacter pylori infection in insulin-dependent diabetes mellitus", Minerva Med, 92, pp.137~144 (2001)
63. Xia HH, "Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus", Am J Gastroenterol, 96, pp.1039~1046 (2001)
64. Stanciu OG, "Helicobacter pylori infection in patients with diabetes mellitus", Rev Med Chir Soc Med Nat Iasi, 107, pp.59~65 (2003)
65. Zelenková J, "Helicobacter pylori and diabetes mellitus", Cas Lek Cesk, 141, pp.575~577 (2002)
66. Kojecký V, "Helicobacter pylori in patients with diabetes mellitus", Vnitr Lek, 39, pp.581~584 (1993)
67. Pietroiusti A, "Cytotoxin-associated gene A strains of Helicobacter pylori represent a risk factor for the development of microalbuminuria in type 2 diabetes", Diabetes Care, 29, pp.1399~1401 (2006)
68. Gasbarrini A, "Insulin-dependent diabetes mellitus affects eradication rate of Helicobacter pylori infection", Eur J Gastroenterol Hepatol, 11, pp.713~716 (1999)
69. Gasbarrini A, "Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus", Scand J Gastroenterol, 35, pp.260~263 (2000)
70. Ojetti V, "High rate of helicobacter pylori re-infection in patients affected by type 1 diabetes", Diabetes Care, 25, pp.1485~ (2002)
71. Sargýn M, "Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori", World J Gastroenterol, 9, pp.1126~1128 (2003)
72. Begue RE, "Helicobacter pylori infection and insulin requirement among children with type 1 diabetes mellitus", Pediatrics, 103, pp.83~ (1999)
73. Solcia E, "Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement", Am J Surg Pathol, 20(1), pp.8~22 (1996)
74. Majka J, "Influence of chronic Helicobacter pylori infection on ischemic cerebral stroke risk factors", Med Sci Monit, 8, pp.675~684 (2002)
75. Chimienti G, "Helicobacter pylori is associated with modified lipid profile : impact on Lipoprotein(a)", Clin Biochem, 36, pp.359~365 (2003)
76. Laurila A, "Association of Helicobacter pylori infection with elevated serum lipids", Atherosclerosis, 142, pp.207~210 (1999)
77. Hoffmeister A, "Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile", Arterioscler Thromb Vasc Biol, 21, pp.427~432 (2001)
78. Niemelä S, "Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations?", Heart, 75, pp.573~575 (1996)
79. Feingold KR, "Role of cytokines in inducing hyperlipidemia", Diabetes, 41(2), pp.97~101 (1992)
80. Pieniazek P, "Association of Helicobacter pylori infection with coronary heart disease", J Physiol Pharmacol, 50, pp.743~751 (1999)
81. Kowalski M., "Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty: the detection of H. pylori specific DNA in human coronary atherosclerotic plaque", J Physiol Pharmacol, 52(1), pp.3~31 (2001)
82. Elizalde JI, "Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen", Aliment Pharmacol Ther, 16, pp.577~586 (2002)
83. Adiloglu AK, "Infection with Chlamydia pneumoniae but not Helicobacter pylori is related to elevated apolipoprotein B levels", Acta Cardiol, 60, pp.599~604 (2005)
84. Scharnagl H, "Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterol", Am J Cardiol, 93, pp.219~220 (2004)
85. Kamada T, "Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients", Dig Liver Dis, 37, pp.39~43 (2005)
86. Chen XH, "Helicobacter pylori infection enhances atherosclerosis in high-cholesterol diet fed C57BL", 6 mice, 2010, pp.38, 259~263
87. Mach F, "Influence of Helicobacter pylori infection during atherogenesis in vivo in mice", Circ Res, 90, pp.1~4 (2002)
88. Ayada K, "Chronic infections and atherosclerosis", Ann N Y Acad Sci, 1108, pp.594~602 (2007)
89. Jafarzadeh A, "Serum concentrations of Helicobacter pylori IgG and the virulence factor CagA in patients with ischaemic heart disease", East Mediterr Health J, 16, pp.1039~1044 (2010)
90. Niccoli G, "Coronary atherosclerotic burden in patients with infection by CagApositive strains of Helicobacter pylori", Coron Artery Dis, 21, pp.217~221 (2010)
91. Huang B, "CagA-positive Helicobacter pylori strains enhanced coronary atherosclerosis by increasing serum OxLDL and HsCRP in patients with coronary heart disease", Dig Dis Sci, 56, pp.109~114 (2011)
92. Fagoonee S, "Potential link between Helicobacter pylori and ischemic heart disease: does the bacterium elicit thrombosis?", Minerva Med, 101, pp.121~125 (2010)
93. Heuschmann PU, "Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes : results from a population-based case-control study", Stroke, 32, pp.2253~2258 (2001)
94. Whincup PH, "Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men", Heart, 75, pp.568~572 (1996)
95. Markus HS, "Helicobacter pylori infection : a risk factor for ischaemic cerebrovascular disease and carotid atheroma", J Neurol Neurosurg Psychiatry, 64, pp.104~107 (1998)
96. Grau AJ, "Helicobacter pylori infection as an independent risk factor for cerebral ischemia of atherothrombotic origin", J Neurol Sci, 186, pp.1~5 (2001)
97. Ponzetto A, "Association of Helicobacter pylori infection with ischemic stroke of non-cardiac origin: the BAT.MA.N. project study", Hepatogastroenterology, 49, pp.631~634 (2002)
98. Danesh J., "Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: meta-analyses of prospective studies", Am Heart J, 138(5), pp.434~437 (1999)
99. Diomedi M, "Cytotoxinassociated Gene-A-positive Helicobacter pylori strains infection increases the risk of recurrent atherosclerotic stroke", Helicobacter, 13, pp.525~531 (2008)
100. Suzuki H, "Extragastric manifestations of Helicobacter pylori infection", Helicobacter, 16(1), pp.65~69 (2011)

관련 논문AI추천